Cite
HARVARD Citation
Sadnicka, A. et al. (2011). Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis. Journal of neurology, neurosurgery and psychiatry. 82 (2), pp. 230-232. [Online].